Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain

Neuropathic pain conditions including neuropathic orofacial pain (NOP) are difficult to treat. Contemporary therapeutic agents for neuropathic pain are often ineffective in relieving pain and are associated with various adverse effects. Finding new options for treating neuropathic pain is a major pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Mohammad Zakir, Ando, Hiroshi, Unno, Shumpei, Kitagawa, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073137/
https://www.ncbi.nlm.nih.gov/pubmed/32093166
http://dx.doi.org/10.3390/ijms21041423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073137/
https://www.ncbi.nlm.nih.gov/pubmed/32093166
http://dx.doi.org/10.3390/ijms21041423

Ejemplares similares